Syndax Pharmaceuticals (SNDX) FCF Margin (2015 - 2026)
Syndax Pharmaceuticals (SNDX) recorded quarterly FCF Margin of 77.62% in Q1 2026, up 23.29% quarter-over-quarter from 101.19% in Q4 2025, and up 39720.0% on a YoY basis from N/an in Q1 2025.
Syndax Pharmaceuticals (SNDX) FCF Margin (2015 - 2026) Analysis & Trends
Syndax Pharmaceuticals' FCF Margin history runs 10 years deep, the most recent figure standing at 77.62% for Q1 2026.
- In Q1 2026, FCF Margin rose 39720.0% year-over-year to 77.62%; the TTM figure through Mar 2026 stood at 127.96% (up 52735.0% YoY), while the FY2025 annual figure was 187.5%, up 97340.0% from the prior year.
- FCF Margin was 77.62% for Q1 2026 at Syndax Pharmaceuticals, up from 101.19% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 77.62% in Q1 2026 to a low of 2047.0% in Q2 2024.
- Historically, FCF Margin has averaged 541.44% across 3 years, with a median of 353.05% in 2025.
- Biggest YoY gain for FCF Margin was 181570 bps in 2025; the steepest drop was 34481 bps in 2025.
- A 3-year view of FCF Margin shows it stood at 747.24% in 2024, then jumped by 86 bps to 101.19% in 2025, then increased by 23 bps to 77.62% in 2026.
- The last three FCF Margin figures came in at 77.62% (Q1 2026), 101.19% (Q4 2025), and 153.77% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Syndax Pharmaceuticals | 1.69 Bn | 1.34 Bn | 53.02 Mn | -77.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77.62% |
| Dec 31, 2025 | -101.19% |
| Sep 30, 2025 | -153.77% |
| Jun 30, 2025 | -231.30% |
| Mar 31, 2025 | -474.81% |
| Dec 31, 2024 | -747.24% |
| Sep 30, 2024 | -498.58% |
| Jun 30, 2024 | -2,047.00% |
| Dec 31, 2021 | 79.56% |
| Sep 30, 2021 | -201.57% |
| Jun 30, 2021 | -6,344.33% |
| Mar 31, 2021 | -5,960.16% |
| Dec 31, 2020 | -4,113.42% |
| Sep 30, 2020 | -4,827.70% |
| Jun 30, 2020 | -5,648.28% |
| Mar 31, 2020 | -4,201.85% |
| Dec 31, 2019 | -3,349.21% |
| Sep 30, 2019 | -2,250.40% |
| Jun 30, 2019 | -3,304.75% |
| Mar 31, 2019 | -4,440.90% |